Trexquant Investment’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
Trexquant Investment's NUVB Position: Q3 2026 in Review
Trexquant Investment reduced its Nuvation Bio (NUVB) stake by 25% in Q3 2026, selling an estimated $753K and leaving 364,981 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #1245.
Trexquant Investment first reported a position in NUVB in Q2 2021 and has held it in 7 quarters since. The position peaked at $2.76M in Q2 2026. 259 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Trexquant Investment held 364,981 shares of Nuvation Bio worth $2.04M as of Q3 2026.
- Trexquant Investment sold 120,077 Nuvation Bio shares in Q3 2026, an estimated $753K.
- Nuvation Bio made up 0.01% of Trexquant Investment's portfolio in Q3 2026, its #1245 holding.
- Trexquant Investment first reported a position in Nuvation Bio in Q2 2021 and has held it in 7 quarters since.
- Trexquant Investment's Nuvation Bio position peaked at $2.76M in Q2 2026.
- 259 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.